Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells

Diabetologia

Volumn 47, Issue 2, 2004, Pages 225-239

  Ylipaasto, P ^a   Klingel, K ^b   Lindberg, A M ^c   Otonkoski, T ^d   Kandolf, R ^b   Hovi, T ^a   Roivainen, M ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c LINNAEUS UNIVERSITY   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Beta cells; Coxsackievirus; Echovirus; Enterovirus; Human pancreas; Islets; Poliovirus; Receptors

Indexed keywords

ARGININE; ASPARTIC ACID; DECAY ACCELERATING FACTOR; GLYCINE; VIRUS ANTIBODY; VIRUS RECEPTOR; VIRUS RNA; VITRONECTIN RECEPTOR;

ANTIBODY SPECIFICITY; ARTICLE; AUTOPSY; CELL CULTURE; CELL LINE; CELL PROTECTION; CELL SURFACE; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; ENTEROVIRUS; ENTEROVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULE; NEWBORN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PARECHOVIRUS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; AUTOPSY; CELL SURVIVAL; CELLS, CULTURED; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; ECHOVIRUS 9; ENTEROVIRUS; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; IN SITU HYBRIDIZATION; INFANT; INFANT, NEWBORN; INFLAMMATION; INSULIN; INTEGRIN ALPHAVBETA3; ISLETS OF LANGERHANS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PANCREAS; PARECHOVIRUS; POLIOVIRUS; RECEPTORS, VIRUS; RNA, VIRAL;

EID: 1542345055     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1297-z     Document Type: Article

References (72)

1. Yoon JW, Austin M, Onodera T, Notkins AL (1979) Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173-1179
2. Yoon JW (1990) The role of viruses and environmental factors in the induction of diabetes. Curr Top Microbiol Immunol 164:95-123
3. King ML, Shaikh A, Bidwell D, Voller A, Banatvala JE (1983) Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet 1:1397-1399
4. Banatvala JE, Bryant J, Schernthaner G et al. (1985) Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1:1409-1412
5. Frisk G, Nilsson E, Tuvemo T, Friman G, Diderholm H (1992) The possible role of Coxsackie A and echo viruses in the pathogenesis of type I diabetes mellitus studied by IgM analysis. J Infect 24:13-22
6. Helfand RF, Gary HE Jr, Freeman CY, Anderson LJ, Pallansch MA (1995) Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. J Infect Dis 172:1206-1211
7. Dahlquist GG, Ivarsson S, Lindberg B, Forsgren M (1995) Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM: A population-based case-control study. Diabetes 44:408-413
8. Hyoty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 44:652-657
9. Clements GB, Galbraith DN, Taylor KW (1995) Coxsackie B virus infection and onset of childhood diabetes. Lancet 346:221-223
10. Hiltunen M, Hyoty H, Knip M et al. (1997) Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J Infect Dis 175:554-560
11. Andreoletti L, Hober D, Hober-Vandenberghe C et al. (1998) Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients. Clin Diagn Virol 9:125-133
12. Lonnrot M, Salminen K, Knip M et al. (2000) Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 61:214-220
13. Chehadeh W, Weill J, Vantyghem MC et al. (2000) Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 181:1929-1939
14. Yin H, Berg AK, Tuvemo T, Frisk G (2002) Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 51:1964-1971
15. Craig ME, Howard NJ, Silink M, Rawlinson WD (2003) Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. J Infect Dis 187:1562-1570
16. King AMQ, Brown F, Christian P, Hovi T, Hyypiä T, Knowles NJ, Lemon SM, Minor PD, Palmenberg AC, Skern T, Stanway G. (2000) Family Picornaviridae. In: Van Regenmortel MHV, Fauquet CM, Bishop DHL, Calisher CH, Carsten EB, Estes MK, Lemon SM, Maniloff J, Mayo MA, McGeoch DJ, Pringle CR, Wickner RB (eds) Virus taxonomy. Seventh Report of the International Committee for the Taxonomy of Viruses. Academic Press, New York San Diego, pp 657-678
17. Mendelsohn CL, Wimmer E, Racaniello VR (1989) Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855-865
18. Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD (1997) Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol 71:4736-4743
19. Roivainen M, Piirainen L, Hovi T et al. (1994) Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 203:357-365
20. Stanway G, Kalkkinen N, Roivainen M et al. (1994) Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol 68:8232-8238
21. Paananen A, Ylipaasto P, Rieder E, Hovi T, Galama J, Roivainen M (2003) Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child. J Med Virol 69:529-537
22. Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW (1992) Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718-1720
23. Marjomaki V, Pietiainen V, Matilainen H et al. (2002) Internalization of echovirus 1 in caveolae. J Virol 76:1856-1865
24. Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW (1994) Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 91:6245-6249
25. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD (1995) Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69:3873-3877
26. Bergelson JM, Cunningham JA, Droguett G et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323
27. Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW (1997) Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 175:697-700
28. Tomko RP, Xu R, Philipson L (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 94:3352-3356
29. Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW (1995) Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69:1903-1906
30. Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW (1998) Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J Gen Virol 79:1707-1713
31. Schmidtke M, Selinka HC, Heim A et al. (2000) Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Virology 275:77-88
32. Triantafilou K, Fradelizi D, Wilson K, Triantafilou M (2002) GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. J Virol 76:633-643
33. Roivainen M, Narvanen A, Korkolainen M, Huhtala ML, Hovi T (1991) Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique. Virology 180:99-107
34. Roivainen M, Piirainen L, Hovi T (1996) Efficient RGD-independent entry process of coxsackievirus A9. Arch Virol 141:1909-1919
35. Roivainen M, Knip M, Hyoty H et al. (1998) Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 56:74-78
36. Yoon JW, Onodera T, Jenson AB, Notkins AL (1978) Virus-induced diabetes mellitus. XL. Replication of coxsackievirus B3 in human pancreatic beta cell cultures. Diabetes 27:778-781
37. Roivainen M, Rasilainen S, Ylipaasto P et al. (2000) Mechanisms of coxsackievirus-induced damage to human pancreatic beta cells. J Clin Endocrinol Metab 85:432-440
38. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T (2002) Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45:693-702
39. Frisk G, Diderholm H (2000) Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release. Int J Exp Diabetes Res 1:165-175
40. Chehadeh W, Kerr-Conte J, Pattou F et al. (2000) Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 74:10153-10164
41. Ross ME, Hayashi K, Notkins AL (1974) Virus-induced pancreatic disease: alterations in concentration of glucose and amylase in blood. J Infect Dis 129:669-676
42. Szopa TM, Dronfield DM, Ward T, Taylor KW (1989) In vivo infection of mice with Coxsackie B4 virus induces long-term functional changes in pancreatic islets with minimal alteration in blood glucose. Diabet Med 6:314-319
43. Vuorinen T, Nikolakaros G, Simell O, Hyypia T, Vainionpaa R (1992) Mumps and Coxsackie B3 virus infection of human fetal pancreatic islet-like cell clusters. Pancreas 7:460-464
44. See DM, Tilles JG (1995) Pathogenesis of virus-induced diabetes in mice. J Infect Dis 171:1131-1138
45. Arola A, Kalimo H, Ruuskanen O, Hyypia T (1995) Experimental myocarditis induced by two different coxsackievirus B3 variants: aspects of pathogenesis and comparison of diagnostic methods. J Med Virol 47:251-259
46. Klingel K, Stephan S, Sauter M et al. (1996) Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol 70:8888-8895
47. Ramsingh AI, Chapman N, Tracy S (1997) Coxsackieviruses and diabetes. Bioessays 19:793-800
48. Foulis AK, Farquharson MA, Cameron SO, McGill M, Schonke H, Kandolf R (1990) A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with Type 1 insulin-dependent diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 33:290-298
49. Klingel K, Hohenadl C, Canu A et al. (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 89:314-318
50. Vreugdenhil GR, Schloot NC, Hoorens A et al. (2000) Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways. Clin Infect Dis 31:1025-1031
51. Kinoshita T, Medof ME, Silber R, Nussenzweig V (1985) Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 162:75-92
52. Hsu KH, Lonberg-Holm K, Alstein B, Crowell RL (1988) A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol 62:1647-1652
53. Hovi T, Roivainen M (1993) Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus. J Clin Microbiol 31:1083-1087
54. Hinegardner RT (1971) An improved fluorometric assay for DNA. Anal Biochem 39:197-201
55. Otonkoski T, Beattie GM, Mally MI, Ricordi C, Hayek A (1993) Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J Clin Invest 92:1459-1466
56. Otonkoski T, Hayek A (1995) Constitution of a biphasic insulin response to glucose in human fetal pancreatic beta-cells with glucagon-like peptide 1. J Clin Endocrinol Metab 80:3779-3783
57. Vella C, Brown CL, McCarthy DA (1992) Coxsackievirus B4 infection of the mouse pancreas: acute and persistent infection. J Gen Virol 73:1387-1394
58. Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N (2002) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373-382
59. Foulis AK, McGill M, Farquharson MA, Hilton DA (1997) A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 40:53-61
60. Buesa-Gomez J, de la Torre JC, Dyrberg T et al. (1994) Failure to detect genomic viral sequences in pancreatic tissues from two children with acute-onset diabetes mellitus. J Med Virol 42:193-197
61. Ris F, Hammar E, Bosco D et al. (2002) Impact of integrin-matrix matching and inhibition of apoptosis on the survival of purified human beta-cells in vitro. Diabetologia 45:841-850
62. Lublin DM, Atkinson JP (1989) Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol 7:35-58
63. Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, Whitton JL (2000) Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271:276-288
64. Lange R, Peng X, Wimmer E, Lipp M, Bernhardt G (2001) The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology 285:218-227
65. Martino TA, Petric M, Weingartl H et al. (2000) The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271:99-108
66. Goodfellow IG, Sioofy AB, Powell RM, Evans DJ (2001) Echoviruses bind heparan sulfate at the cell surface. J Virol 75:4918-4921
67. Goodfellow IG, Powell RM, Ward T, Spiller OB, Almond JW, Evans DJ (2000) Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59. J Gen Virol 81:1393-1401
68. Berinstein A, Roivainen M, Hovi T, Mason PW, Baxt B (1995) Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol 69:2664-2666
69. Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER (1998) beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA 95:7074-7079
70. Roivainen M, Hyypia T, Piirainen L, Kalkkinen N, Stanway G, Hovi T (1991) RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol 65:4735-4740
71. Joki-Korpela P, Marjomaki V, Krogerus C, Heino J, Hyypia T (2001) Entry of human parechovirus 1. J Virol 75:1958-1967
72. Reagan KJ, Goldberg B, Crowell RL (1984) Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol 49:635-640